Mounjaro®
Starting from £179.99/mo
Start journey Learn morePersistent diarrhoea on Mounjaro is one of the most common gastrointestinal side effects reported during treatment, and for many people it raises an urgent practical question: is this expected, or is something wrong? Loose stools that appear shortly after starting or increasing a dose are well documented in clinical data — the NHS lists diarrhoea among tirzepatide's most frequently reported effects. The key decision isn't whether it can happen; it's whether what you're experiencing sits within the normal pattern or signals something that needs medical attention. Mounjaro is a prescription-only medicine, and any concerns about ongoing symptoms should be discussed with the prescriber who reviewed your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro slows gastric emptying and changes the way your gut processes food. That shift affects bowel habits for many people, and loose or more frequent stools in the first couple of weeks after a new dose are genuinely expected. Tirzepatide's clinical programme found gastrointestinal effects to be the most commonly reported side effects overall, with diarrhoea featuring across all dose levels as one of the most discussed aspects of Mounjaro's gut impact.
The pattern that falls within normal bounds looks roughly like this: diarrhoea appears within a day or two of an injection, is loose rather than severe, and begins to ease within one to two weeks as your body adapts. If you've just moved from 2.5mg to 5mg, for instance, you may find the adjustment period repeats, that's the gut responding to a higher level of the medicine.
What sits outside that pattern is diarrhoea that is constant rather than episodic, that hasn't improved after two to three weeks at a stable dose, or that is severe enough to leave you unable to eat or drink normally. That's not something to monitor indefinitely at home. The full side-effect profile of Mounjaro covers more about what the clinical trial data and the patient information leaflet describe as typical versus concerning.
Some symptoms alongside diarrhoea require prompt attention rather than a wait-and-see approach. Contact your GP, prescriber or 111 the same day if you experience any of the following.
Signs of significant dehydration: dizziness when standing, a dry mouth, very dark urine, or noticeably reduced urination. Diarrhoea that is watery and relentless (not a loose stool once or twice a day but repeated urgent episodes) can strip fluids quickly, and Mounjaro's effects on the kidney are relevant here because the NHS notes that severe fluid loss may affect kidney function.
Severe abdominal pain that is persistent and radiates towards your back, with or without vomiting, is a separate concern. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines highlighting acute pancreatitis as an infrequent but serious side effect, the MHRA's Yellow Card scheme asks patients to report this kind of symptom, and the guidance is clear: seek urgent medical help if this combination of pain occurs. Diarrhoea alone is unlikely to indicate pancreatitis, but severe gut pain alongside it should never be dismissed.
If you have a history of pancreatic conditions, it's worth reading what the evidence says about tirzepatide for people with a pancreatitis history before assuming symptoms are routine. Call 999 or go to A&E if you feel seriously unwell.
If the diarrhoea is uncomfortable but not alarming (there's no severe pain, no sign of dehydration, and you're managing to keep fluids down) there are sensible steps to take while you assess whether it's settling.
Hydration is the most important. Plain water throughout the day, small sips frequently rather than large amounts at once. Many people find that eating smaller meals and avoiding high-fat foods reduces the severity of GI symptoms on Mounjaro, which makes sense given the medicine's effect on fat metabolism and gastric emptying. The NHS's guidance on tirzepatide side effects and self-care steps is a reliable starting point alongside your patient information leaflet.
Timing your injection may also help some people, though any change to how you're using the medicine should be discussed with your prescriber rather than decided unilaterally. The same applies to dose adjustments: if constant diarrhoea is affecting your daily life, that's a clinical conversation, not a decision to make alone. Some people find the transition between constipation and looser stools confusing; if your symptoms alternate, the pattern of constipation followed by diarrhoea on Mounjaro has its own clinical explanation worth understanding.
For strategies specifically aimed at reducing loose stools during treatment, practical approaches for managing diarrhoea on Mounjaro covers what's supported by clinical advice. And if you want a broader view of how diarrhoea features as a side effect of Mounjaro across different doses and stages of treatment, that's a useful companion read alongside the general overview.
At nume, every consultation is read by a GPhC-registered Independent Prescriber, a real clinician, not an automated triage system. If you're already on treatment through us and constant diarrhoea is affecting you, our aftercare team is available seven days a week. You don't have to wait for a scheduled review.
During a consultation (whether a first assessment or a repeat review) prescribers look at the full picture: how long symptoms have been present, their severity, whether you're managing hydration, and whether a dose change might be appropriate. That conversation might conclude that your body simply needs more time. It might also lead to a temporary pause or a different titration plan. One thing it won't do is leave you making that call alone at half eleven on a Tuesday morning before the school run, trying to decide whether this counts as an emergency.
If you're considering starting Mounjaro and want to understand how side effects like this are monitored and managed, checking your eligibility through a free consultation is where that discussion begins. Our prescribers cover side-effect expectations as a routine part of the clinical review, so you go in knowing what to watch for.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.